Repositioning of the global epicentre of non-optimal cholesterol

Keyphrases

• Cholesterol 100%
• Non-high-density Lipoprotein Cholesterol (non-HDL-C) 100%
• High-density Lipoprotein Cholesterol (HDL-C) 80%
• East Asia 60%
• South-East Asia 60%
• Northwestern Europe 40%
• Sweden 20%
• Population-based 20%
• Finland 20%
• Population-based Study 20%
• North America 20%
• Asia 20%
• Western Europe 20%
• Lipids 20%
• Iceland 20%
• Norway 20%
• Greenland 20%
• Belgium 20%
• High-income Countries 20%
• Low-middle Income Countries 20%
• Western Countries 20%
• Switzerland 20%
• Blood Lipids 20%
• Effects on Humans 20%
• Thailand 20%
• High-income 20%
• Policy Intervention 20%
• Access to Treatment 20%
• Oceania 20%
• Central and Eastern Europe 20%
• South Asia 20%
• Credible Interval 20%
• Malaysia 20%
• Personal Intervention 20%
• Non-high-density Lipoprotein 20%
• High Cholesterol 20%
• WorldView-3 20%
• Cardiovascular Risk Markers 20%
• Lipid-lowering Medications 20%
• Distinctive Features 20%
• Tokelau 20%
• Behavioral Determinants 20%
• Blood Cholesterol 20%
• Philippines 20%
• Global Analysis 20%
• Malta 20%
• Dietary Determinants 20%
• Net Effect 20%

Agricultural and Biological Sciences

• High-Density Lipoprotein 28%